The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
|
---|---|
Published in |
Frontiers in Pharmacology, December 2022
|
DOI | 10.3389/fphar.2022.1072202 |
Pubmed ID | |
Authors |
Rana Abdelnabi, Piet Maes, Steven de Jonghe, Birgit Weynand, Johan Neyts |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 5 | 21% |
Student > Ph. D. Student | 2 | 8% |
Lecturer | 1 | 4% |
Researcher | 1 | 4% |
Professor > Associate Professor | 1 | 4% |
Other | 1 | 4% |
Unknown | 13 | 54% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 5 | 21% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 8% |
Immunology and Microbiology | 1 | 4% |
Social Sciences | 1 | 4% |
Chemistry | 1 | 4% |
Other | 1 | 4% |
Unknown | 13 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2023.
All research outputs
#7,923,746
of 24,022,746 outputs
Outputs from Frontiers in Pharmacology
#3,622
of 17,871 outputs
Outputs of similar age
#145,938
of 443,294 outputs
Outputs of similar age from Frontiers in Pharmacology
#112
of 994 outputs
Altmetric has tracked 24,022,746 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 17,871 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,294 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 994 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.